XLRN
Westfield Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-894,898
| Closed | -$154M | – | 277 |
|
|
2021
Q3 | $154M | Buy |
894,898
+39,254
| +5% | +$6.76M | 0.93% | 23 |
|
|
2021
Q2 | $107M | Buy |
855,644
+16,371
| +2% | +$2.05M | 0.64% | 46 |
|
|
2021
Q1 | $114M | Sell |
839,273
-26,234
| -3% | -$3.56M | 0.71% | 44 |
|
|
2020
Q4 | $111M | Buy |
865,507
+18,358
| +2% | +$2.35M | 0.66% | 48 |
|
|
2020
Q3 | $95.3M | Buy |
847,149
+182,155
| +27% | +$20.5M | 0.62% | 54 |
|
|
2020
Q2 | $63.4M | Buy |
664,994
+19,630
| +3% | +$1.87M | 0.44% | 77 |
|
|
2020
Q1 | $58M | Sell |
645,364
-505,455
| -44% | -$45.4M | 0.51% | 69 |
|
|
2019
Q4 | $61M | Sell |
1,150,819
-86,212
| -7% | -$4.57M | 0.43% | 82 |
|
|
2019
Q3 | $48.9M | Buy |
1,237,031
+16,870
| +1% | +$667K | 0.39% | 88 |
|
|
2019
Q2 | $50.1M | Sell |
1,220,161
-156,962
| -11% | -$6.45M | 0.38% | 94 |
|
|
2019
Q1 | $64.1M | Buy |
1,377,123
+84,410
| +7% | +$3.93M | 0.49% | 70 |
|
|
2018
Q4 | $56.3M | Buy |
1,292,713
+108,405
| +9% | +$4.72M | 0.48% | 77 |
|
|
2018
Q3 | $67.8M | Buy |
1,184,308
+389,265
| +49% | +$22.3M | 0.48% | 72 |
|
|
2018
Q2 | $38.6M | Sell |
795,043
-579,155
| -42% | -$28.1M | 0.29% | 113 |
|
|
2018
Q1 | $53.7M | Sell |
1,374,198
-136,670
| -9% | -$5.34M | 0.41% | 87 |
|
|
2017
Q4 | $64.1M | Sell |
1,510,868
-30,770
| -2% | -$1.31M | 0.49% | 72 |
|
|
2017
Q3 | $57.5M | Sell |
1,541,638
-140,721
| -8% | -$5.25M | 0.44% | 85 |
|
|
2017
Q2 | $51.1M | Buy |
1,682,359
+534,440
| +47% | +$16.2M | 0.44% | 86 |
|
|
2017
Q1 | $30.4M | Sell |
1,147,919
-104,490
| -8% | -$2.77M | 0.26% | 126 |
|
|
2016
Q4 | $32M | Buy |
1,252,409
+772,524
| +161% | +$19.7M | 0.28% | 120 |
|
|
2016
Q3 | $17.4M | Sell |
479,885
-14,315
| -3% | -$518K | 0.14% | 179 |
|
|
2016
Q2 | $16.8M | Buy |
+494,200
| New | +$16.8M | 0.14% | 177 |
|